Valuation: Virbac

Market Cap 2.76B 3.19B 2.59B 2.36B 4.43B 305B 4.49B 30.31B 11.88B 153B 11.99B 11.73B 509B P/E 2026 *
16.1x
P/E 2027 * 14.6x
Enterprise Value 2.88B 3.34B 2.7B 2.46B 4.63B 319B 4.7B 31.71B 12.42B 160B 12.54B 12.27B 532B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.72x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
1 day-1.05%
1 week-1.50%
Current month-2.52%
1 month+0.92%
3 months-6.00%
6 months-9.99%
Current year-7.97%
1 week 329
Extreme 329
340
1 month 324
Extreme 324
350
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap.
4/22/24 A Sell

Chief Executive Officer

810 0.0096%
4/22/24 A Sell

Chief Executive Officer

140 0.0017%
4/22/24 A Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-1.50%-0.60%+20.07% 3.23B
-1.11%-2.49%-52.65%-60.08% 30.49B
-0.25%+5.97%+31.46%+106.02% 11.83B
+2.54%-1.28%-18.09%+3.93% 3.77B
-0.15%-3.29%+51.29%+36.74% 2.19B
-1.70%-1.70%+11.81%+20.24% 1.97B
+0.79%+1.41%+12.91%+131.64% 1.39B
-1.77%+2.88%-16.99%+4.71% 1.3B
+0.30%-1.05%-12.47%-44.77% 996M
-0.71%-2.36%-5.63%-23.64% 954M
Average -0.31%+0.46%+0.10%+19.49% 5.81B
Weighted average by Cap. -0.62%-0.11%-20.48%-4.40%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.46B 1.33B 2.49B 172B 2.53B 17.06B 6.68B 86.06B 6.74B 6.6B 286B 1.65B 1.91B 1.55B 1.41B 2.65B 182B 2.68B 18.12B 7.1B 91.4B 7.16B 7.01B 304B
Net income 171M 198M 161M 146M 275M 18.95B 279M 1.88B 737M 9.49B 744M 728M 31.58B 190M 220M 178M 162M 305M 20.99B 309M 2.08B 817M 10.52B 824M 806M 34.99B
Net Debt 127M 147M 119M 108M 204M 14.04B 206M 1.39B 546M 7.03B 551M 539M 23.39B 75.16M 87.06M 70.51M 64.22M 121M 8.32B 122M 827M 324M 4.17B 327M 320M 13.87B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
17/08/26 €329.00 -1.05% 1,965
14/08/26 €332.50 +0.30% 1,338
13/08/26 €331.50 -0.60% 1,961
12/08/26 €333.50 -1.91% 2,867
11/08/26 €340.00 +1.80% 4,851
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
329.00EUR
Average target price
411.88EUR
Spread / Average Target
+25.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock